List of insiders holdings for 4D Molecular Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2026-02-17 16:12:05 | 5,847,281 0 | 5,847,281 | Form 13G |
| 2 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 2026-02-17 16:15:18 | 5,713,852 0 | 5,713,852 | Form 13G |
| 3 | YAO TONY DUNG LING Director | 2020-12-17 17:39:31 | 2,864 1,060,880 | 1,063,744 | Form 4 |
| 4 | Kirn David Chief Executive Officer | 2026-03-27 16:30:07 | 750,000 0 | 750,000 | Form 4 |
| 5 | Humer Kristian Chief Financial Officer | 2025-12-11 16:18:02 | 480,000 0 | 480,000 | Form 4 |
| 6 | Moretti August J Chief Financial Officer | 2023-05-16 20:52:00 | 228,105 0 | 228,105 | Form 4 |
| 7 | Simms Christopher Paul See Remarks | 2026-03-27 16:30:02 | 219,000 0 | 219,000 | Form 4 |
| 8 | Bizily Scott Chief Legal Officer | 2026-03-27 16:30:03 | 217,000 0 | 217,000 | Form 4 |
| 9 | Kamal Fariborz President & COO | 2025-03-10 19:56:53 | 178,400 0 | 178,400 | Form 4 |
| 10 | Mehra Uneek See Remarks | 2025-03-10 19:57:50 | 130,000 0 | 130,000 | Form 4 |
| 11 | Kim Robert Young Chief Medical Officer | 2025-03-10 19:58:05 | 92,300 0 | 92,300 | Form 4 |
| 12 | Gupta Ashoo VP, Finance and Controller | 2026-03-24 18:30:41 | 62,261 0 | 62,261 | Form 4 |
| 13 | FISHMAN ROBERT S Chief Medical Officer | 2022-09-06 20:42:21 | 60,000 0 | 60,000 | Form 4 |
| 14 | SBLENDORIO GLENN Director | 2026-01-07 21:12:50 | 45,000 0 | 45,000 | Form 4 |
| 15 | THEUER CHARLES Director | 2025-12-16 16:35:36 | 41,684 0 | 41,684 | Form 4 |
| 16 | Zimmermann Carolyne Chief Business Officer | 2022-02-03 17:42:54 | 35,000 0 | 35,000 | Form 4 |
| 17 | MILLIGAN JOHN F Director | 2025-06-20 16:03:35 | 33,750 0 | 33,750 | Form 4 |
| 18 | Miller-Rich Nancy Director | 2025-06-20 16:04:06 | 22,500 0 | 22,500 | Form 4 |
| 19 | Chacko Jacob Director | 2025-06-20 16:05:35 | 22,500 0 | 22,500 | Form 4 |
| 20 | GRAY SUSANNAH Director | 2025-06-20 16:05:18 | 22,500 0 | 22,500 | Form 4 |
| 21 | Tomasello Shawn Director | 2025-06-20 16:04:56 | 22,500 0 | 22,500 | Form 4 |
| 22 | Kasahara Noriyuki Director | 2023-05-25 19:31:19 | 22,500 0 | 22,500 | Form 4 |
| 23 | SCHAFFER DAVID Director | 2022-02-14 16:32:05 | 0 0 | 0 | Form 13G |
| 24 | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2024-11-14 16:31:18 | 0 0 | 0 | Form 13G |
| 25 | Burkoth William T. Director | 2020-12-10 19:11:33 | 0 0 | 0 | Form 3 |